Interpreting elevated liver blood test results through a genetic lens: A genome‐wide association study
Liver International · 2024
DOI: 10.1111/liv.16114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Hamish Innes und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Glucuronosyltransferase, Bilirubin, gamma-Glutamyltransferase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation, MRF, Medical Research Foundation.
Abstract (Originalsprache)
Background and Aims Individuals with genetic polymorphisms in UGT1A1 exhibit bilirubin levels that belie their risk of liver disease (Gilbert's syndrome) but it is not known if this phenomenon extends to other common liver blood tests (LBTs).
Methods
A genome‐wide association analysis of 10 LBTs was conducted using the UK biobank. Polygenic scores (PGS) were created from discordant loci (e.g. loci associated with the LBT but not associated with cirrhosis morbidity risk). Participants were assigned to a low, intermediate or high PGS for each LBT. A high PGS approximates Gilbert's syndrome (i.e. elevated LBT without an analogous increase in disease risk). The prognostic significance of an ‘elevated’ LBT—and how this differs by PGS—was assessed through competing risk survival analysis.
Results
This study included 157 005 and 166 871 participants for the discovery and validation phases, respectively. Elevated LBTs were more prevalent in the high versus low PGS group, yet the 10‐year risk of cirrhosis morbidity was comparable. For example, in the low PGS group, 4.3% had an elevated gamma‐glutamyltransferase (GGT) and the 10‐year risk of cirrhosis morbidity was .45%. Conversely, in the high PGS group, 21.2% had an elevated GGT and the 10‐year risk was .38%. Accordingly, the 10‐year risk of cirrhosis morbidity for individuals with an elevated GGT was markedly different in the low vs. high group (4.2% vs. 1.2%; p < .001). Similar results were apparent for Fibrosis‐4 index, total bilirubin, and platelet count.
Conclusion
Variability in LBTs is influenced by genetic polymorphisms that have a neutral effect on disease risk. These findings have implications for interpreting elevated LBTs in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
- BBV/STI team, Public Health Scotland, Glasgow, UK.
- Lifespan and Population Health, University of Nottingham, Nottingham, UK.
- Medical Department 1, University Hospital Dresden, Dresden, TU, Germany.
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.
- Edinburgh Pathology, University of Edinburgh, Edinburgh, UK.
ORCID-Profile: Hamish Innes, Jonathan A Fallowfield
Förderung
- UK Research and Innovation
- MRF
- Medical Research Foundation
Zitieren
APA
Innes, H., Buch, S., Kendall, T. J., Fallowfield, J. A., & Guha, I. N. (2024). Interpreting elevated liver blood test results through a genetic lens: A genome‐wide association study. Liver International. https://doi.org/10.1111/liv.16114
Vancouver
Innes H, Buch S, Kendall TJ, Fallowfield JA, Guha IN. Interpreting elevated liver blood test results through a genetic lens: A genome‐wide association study. Liver International. 2024. doi:10.1111/liv.16114
BibTeX
@article{Innes2024,
author = {Innes, Hamish and Buch, Stephan and Kendall, Timothy J and Fallowfield, Jonathan A and Guha, Indra Neil},
title = {Interpreting elevated liver blood test results through a genetic lens: A genome‐wide association study},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.16114}
}
EUVIMED